Katharina Lueck
UCL Institute of Ophthalmology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Katharina Lueck.
Investigative Ophthalmology & Visual Science | 2009
Susanne Wasmuth; Katharina Lueck; Hanna Baehler; Albrecht Lommatzsch; Daniel Pauleikhoff
PURPOSE A variation in the complement factor H gene was associated with an enhanced risk to develop especially early age-related macular degeneration. Drusen and basal laminar deposits are hallmarks of this AMD manifestation that contain vitronectin as a major component. In this study, the correlation between complement stimulation and vitronectin production of retinal pigment epithelial (RPE) cells was investigated. METHODS ARPE-19 cells, a permanent cell line of human RPE cells, were supplemented with and without human complement competent serum in medium with and without heat inactivated fetal calf serum. The cells were examined in situ for their vitronectin production as an effective inhibitor of alternatively activated complement by immunohistochemistry. Semi-quantitative RT-PCR and Western blots were performed to analyze vitronectin mRNA and protein. RESULTS A strong immunohistochemical staining for vitronectin was observed after complement supplementation. The enhanced production of this complement inactivator by ARPE-19 cells was confirmed by Western blot, whereas the expression analysis revealed unaltered mRNA amounts. CONCLUSIONS A stimulation of RPE cells with complement resulted in an upregulated production of vitronectin. This may support the concept of a protective mechanism, since vitronectin is the major inhibitor of complement activated by the alternative pathway. On the other hand, this increased vitronectin production after complement stimulation may contribute to focal or diffuse deposits in Bruchs membrane, as observed in early AMD.
Investigative Ophthalmology & Visual Science | 2012
Katharina Lueck; Maren Hennig; Albrecht Lommatzsch; Daniel Pauleikhoff; Susanne Wasmuth
PURPOSE Age-related macular degeneration (AMD) is accompanied by increased complement activation, and by lipofuscin accumulation in retinal pigment epithelial (RPE) cells due to incomplete degradation of photoreceptor outer segments (POS). The influence of POS, ultraviolet (UV)-irradiated POS and human complement sera (HCS) on cytokine secretion from RPE cells was therefore examined. METHODS RPE cells were incubated with POS or UV-POS every other day for 1 week. The autofluorescence (AF) was measured photometrically and by flow cytometry. Senescence-associated genes were analyzed by RT-PCR. Internalization and degradation of POS were determined using phagocytosis and degradation assays, and lysosomal function by neutral red uptake. RPE cells in polycarbonate cell culture inserts were incubated apically with POS or UV-POS and afterward basally with HCS. C7-deficient HCS was used as control. The integrity of the cell monolayer was assessed by measuring the transepithelial electrical resistance (TER) and the permeability. Interleukin (IL)-6, IL-8, monocyte chemoattractant protein-1, and vascular endothelial growth factor were quantified by ELISA. RESULTS POS treatment led to an increased AF and senescence marker expression, which were further elevated in response to UV-POS. UV-POS were preferentially accumulated over POS and the lysosomal function was impaired due to UV-POS. HCS intensified the cytokine production compared with controls. POS had no effect, though UV-POS combined with HCS induced a significant increase in all cytokines. CONCLUSIONS RPE cultivation with UV-POS might serve as a model to investigate the accumulation of lipofuscin-like structures. The enhanced cytokine secretion due to UV-POS with HCS may account for an increased susceptibility for lipofuscin-loaded cells to complement, inducing a proinflammatory environment as observed in AMD.
Ophthalmic Research | 2015
Katharina Lueck; Martin Busch; Stephen E. Moss; John Greenwood; Maren Kasper; Albrecht Lommatzsch; Daniel Pauleikhoff; Susanne Wasmuth
Background/Aims: We examined the effect of human complement sera (HCS) on retinal pigment epithelial (RPE) cells with respect to pro-inflammatory mediators relevant in early age-related macular degeneration (AMD). Methods: RPE cells were treated with complement-containing HCS or with heat-inactivated (HI) HCS or C7-deficient HCS as controls. Cells were analysed for C5b-9 using immunocytochemistry and flow cytometry. Interleukin (IL)-6, IL-8, and monocyte chemoattractant protein-1 (MCP-1) were quantified by ELISA and RT-PCR. Tumour necrosis factor-a (TNF-a), intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), were analysed by Western blotting. The intracellular distribution of nuclear factor (NF)-κB was investigated by immunofluorescence. Results: A concentration-dependent increased staining for C5b-9 but no influence on cell viability was observed after HCS treatment. ELISA and RT-PCR analysis revealed elevated secretion and expression of IL-6, IL-8, and MCP-1. Western blot analysis showed a concentration-dependent increase in ICAM-1, VCAM-1, and TNF-a in response to HCS, and immunofluorescence staining revealed nuclear translocation of NF-κB. Conclusion: This study suggests that complement stimulates NF-κB activation in RPE cells that might further create a pro-inflammatory environment. All these factors together may support early AMD development.
Scientific Reports | 2017
Katharina Lueck; Amanda-Jayne F. Carr; Dimitrios Stampoulis; Volker Gerke; Ursula Rescher; John Greenwood; Stephen E. Moss
The retinoic acid derivative fenretinide (FR) is capable of transdifferentiating cultured retinal pigment epithelial (RPE) cells towards a neuronal-like phenotype, but the underlying mechanisms are not understood. To identify genes involved in this process we performed a microarray analysis of RPE cells pre- and post-FR treatment, and observed a marked down-regulation of AnnexinA8 (AnxA8) in transdifferentiated cells. To determine whether AnxA8 plays a role in maintaining RPE cell phenotype we directly manipulated AnxA8 expression in cultured and primary RPE cells using siRNA-mediated gene suppression, and over-expression of AnxA8-GFP in conjunction with exposure to FR. Treatment of RPE cells with AnxA8 siRNA recapitulated exposure to FR, with cell cycle arrest, neuronal transdifferentiation, and concomitant up-regulation of the neuronal markers calretinin and calbindin, as assessed by real-time PCR and immunofluorescence. In contrast, AnxA8 transient over-expression in ARPE-19 cells prevented FR-induced differentiation. Ectopic expression of AnxA8 in AnxA8-depleted cells led to decreased neuronal marker staining, and normal cell growth as judged by phosphohistone H3 staining, cell counting and cleaved caspase-3 levels. These data show that down-regulation of AnxA8 is both necessary and sufficient for neuronal transdifferentiation of RPE cells and reveal an essential role for AnxA8 as a key regulator of RPE phenotype.
Ophthalmic Research | 2015
Sho-ichi Yamagishi; Satoshi Maeda; Takanori Matsui; Ayako Ojima; Mika Suematsu; Kuniyoshi Kaseda; Yuichiro Higashimoto; Ryoji Yamakawa; António F. Ambrósio; Ana Raquel Santiago; Maria H. Madeira; Flavio Mac Cord Medina; Augusto Motta; Walter Yukihiko Takahashi; Pedro Carlos Carricondo; Mario Martins dos Santos Motta; Mônica Barbosa de Melo; José Paulo Cabral de Vasconcellos; Katharina Lueck; Martin Busch; Stephen E. Moss; John Greenwood; Maren Kasper; Albrecht Lommatzsch; Daniel Pauleikhoff; Susanne Wasmuth; Bart P. Leroy; Tine Vandenbroucke; Ronald Buyl; Julie De Zaeytijd
Basel • Freiburg • Paris • London • New York • Chennai • New Delhi • Bangkok • Beijing • Shanghai • Tokyo • Kuala Lumpur • Singapore • Sydney Journal for Translational and Clinical Research Founded 1970 by O. Hockwin, Bonn, G. Naumann, Hamburg and D.F. Cole, London Continued by O. Hockwin, Bonn (1981–1994); G.F.J.M. Vrensen, Zeist (1994–2003); Uwe Pleyer, Berlin (2003–2014); David E. Pelayes, Buenos Aires, Borja Corcόstegui, Barcelona (2012–2014)
Investigative Ophthalmology & Visual Science | 2015
Katharina Lueck; John Greenwood; Stephen E. Moss
Investigative Ophthalmology & Visual Science | 2014
Apostolos Georgiannakis; Katharina Lueck; John Greenwood; Stephen E. Moss
Investigative Ophthalmology & Visual Science | 2012
Susanne Wasmuth; Katharina Lueck; Albrecht Lommatzsch; Daniel Pauleikhoff
Investigative Ophthalmology & Visual Science | 2011
Susanne Wasmuth; Katharina Lueck; Kerstin Wendland; Albrecht Lommatzsch; Daniel Pauleikhoff
Investigative Ophthalmology & Visual Science | 2011
Katharina Lueck; Susanne Wasmuth; Stephen E. Moss; John Greenwood; Albrecht Lommatzsch; Daniel Pauleikhoff